415 related articles for article (PubMed ID: 32246378)
21. Breast cancer characteristics and surgery among women with Li-Fraumeni syndrome in Germany-A retrospective cohort study.
Rippinger N; Fischer C; Sinn HP; Dikow N; Sutter C; Rhiem K; Grill S; Cremer FW; Nguyen HP; Ditsch N; Kast K; Hettmer S; Kratz CP; Schott S
Cancer Med; 2021 Nov; 10(21):7747-7758. PubMed ID: 34569185
[TBL] [Abstract][Full Text] [Related]
22. Myelodysplastic syndromes arising in patients with germline TP53 mutation and Li-Fraumeni syndrome.
Talwalkar SS; Yin CC; Naeem RC; Hicks MJ; Strong LC; Abruzzo LV
Arch Pathol Lab Med; 2010 Jul; 134(7):1010-5. PubMed ID: 20586629
[TBL] [Abstract][Full Text] [Related]
23. Two metachronous tumors in the radiotherapy fields of a patient with Li-Fraumeni syndrome.
Limacher JM; Frebourg T; Natarajan-Ame S; Bergerat JP
Int J Cancer; 2001 Aug; 96(4):238-42. PubMed ID: 11474498
[TBL] [Abstract][Full Text] [Related]
24. Characteristics of TP53 germline variants and their correlations with Li-Fraumeni syndrome or Li-Fraumeni-like syndrome in Chinese tumor patients.
Tian P; Zhang X; Yang S; Fang Y; Yuan H; Li W; Zhu H; Zhao F; Ding J; Zhu Y; Wang S; Sun G; Ni H; Ma T; Lei T
J Genet Genomics; 2022 Jul; 49(7):645-653. PubMed ID: 35033608
[TBL] [Abstract][Full Text] [Related]
25. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil.
Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P
Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735
[TBL] [Abstract][Full Text] [Related]
26. Identification and Management of
Pal T; Brzosowicz J; Valladares A; Wiesner GL; Laronga C
South Med J; 2017 Oct; 110(10):643-648. PubMed ID: 28973705
[TBL] [Abstract][Full Text] [Related]
27. Genomic and Clinical Correlates of Adrenocortical Carcinoma in an Adult Patient with Li-Fraumeni Syndrome: A Case Report.
Bondy S; Tajzler C; Hotte SJ; Kapoor A; Zbuk K; Lalani AA
Curr Oncol; 2020 Dec; 28(1):226-232. PubMed ID: 33704190
[TBL] [Abstract][Full Text] [Related]
28. The profile and contribution of rare germline copy number variants to cancer risk in Li-Fraumeni patients negative for TP53 mutations.
Silva AG; Krepischi AC; Pearson PL; Hainaut P; Rosenberg C; Achatz MI
Orphanet J Rare Dis; 2014 Apr; 9():63. PubMed ID: 24775443
[TBL] [Abstract][Full Text] [Related]
29. Clinical Features of Li-Fraumeni Syndrome in Korea.
Song R; Kong SY; Choi W; Lee EG; Woo J; Han JH; Lee S; Kang HS; Jung SY
Cancer Res Treat; 2024 Jan; 56(1):334-341. PubMed ID: 37562436
[TBL] [Abstract][Full Text] [Related]
30. [Report of Multidisciplinary Treatment for Sisters with Li-Fraumeni Syndrome].
Suzuki O; Amano K; Chika N; Yamano T; Eguchi H; Nakashima H; Ooya S; Okazaki Y; Mochiki E; Takahashi T; Ishida H
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1947-1949. PubMed ID: 36733053
[TBL] [Abstract][Full Text] [Related]
31. Histopathologic features of breast cancer in Li-Fraumeni syndrome.
Kuba MG; Lester SC; Bowman T; Stokes SM; Taneja KL; Garber JE; Dillon DA
Mod Pathol; 2021 Mar; 34(3):542-548. PubMed ID: 32636452
[TBL] [Abstract][Full Text] [Related]
32. The first two confirmed sub-Saharan African families with germline TP53 mutations causing Li-Fraumeni syndrome.
Macaulay S; Goodyear QC; Kruger M; Chen W; Essop F; Krause A
Fam Cancer; 2018 Oct; 17(4):607-613. PubMed ID: 29392648
[TBL] [Abstract][Full Text] [Related]
33. Contribution of de novo and mosaic
Renaux-Petel M; Charbonnier F; Théry JC; Fermey P; Lienard G; Bou J; Coutant S; Vezain M; Kasper E; Fourneaux S; Manase S; Blanluet M; Leheup B; Mansuy L; Champigneulle J; Chappé C; Longy M; Sévenet N; Paillerets BB; Guerrini-Rousseau L; Brugières L; Caron O; Sabourin JC; Tournier I; Baert-Desurmont S; Frébourg T; Bougeard G
J Med Genet; 2018 Mar; 55(3):173-180. PubMed ID: 29070607
[TBL] [Abstract][Full Text] [Related]
34. Outcomes of Breast Cancer Patients Treated with Accelerated Partial Breast Irradiation Via Multicatheter Interstitial Brachytherapy: The Pooled Registry of Multicatheter Interstitial Sites (PROMIS) Experience.
Kamrava M; Kuske RR; Anderson B; Chen P; Hayes J; Quiet C; Wang PC; Veruttipong D; Snyder M; Jeffrey Demanes D
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S404-11. PubMed ID: 25916980
[TBL] [Abstract][Full Text] [Related]
35. Adjuvant hypofractionated radiotherapy with weekly concomitant boost for women with early breast cancer: the clinical experience at Genoa university.
Corvò R; Ricchetti F; Doino D; Torielli P; Agostinelli S; Cavagnetto F; Giannelli F; D'Alonzo A; Vagge S; Belgioia L; Guenzi M
Anticancer Res; 2010 Nov; 30(11):4749-53. PubMed ID: 21115935
[TBL] [Abstract][Full Text] [Related]
36. Germline TP53 Mutation and Clinical Characteristics of Korean Patients With Li-Fraumeni Syndrome.
Park KJ; Choi HJ; Suh SP; Ki CS; Kim JW
Ann Lab Med; 2016 Sep; 36(5):463-8. PubMed ID: 27374712
[TBL] [Abstract][Full Text] [Related]
37. Breast cancer in patients with Li-Fraumeni syndrome - a case-series study and review of literature.
Nandikolla AG; Venugopal S; Anampa J
Breast Cancer (Dove Med Press); 2017; 9():207-215. PubMed ID: 28356770
[TBL] [Abstract][Full Text] [Related]
38. TP53 and CDKN1A mutation analysis in families with Li-Fraumeni and Li-Fraumeni like syndromes.
Andrade RC; Dos Santos AC; de Aguirre Neto JC; Nevado J; Lapunzina P; Vargas FR
Fam Cancer; 2017 Apr; 16(2):243-248. PubMed ID: 27714481
[TBL] [Abstract][Full Text] [Related]
39. Current review of TP53 pathogenic germline variants in breast cancer patients outside Li-Fraumeni syndrome.
Fortuno C; James PA; Spurdle AB
Hum Mutat; 2018 Dec; 39(12):1764-1773. PubMed ID: 30240537
[TBL] [Abstract][Full Text] [Related]
40. Prevalence of germline TP53 mutations in HER2+ breast cancer patients.
Rath MG; Masciari S; Gelman R; Miron A; Miron P; Foley K; Richardson AL; Krop IE; Verselis SJ; Dillon DA; Garber JE
Breast Cancer Res Treat; 2013 May; 139(1):193-8. PubMed ID: 23580068
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
